HomeCompareBMXMF vs BTI

BMXMF vs BTI: Dividend Comparison 2026

BMXMF yields 1.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXMF wins by $4.58M in total portfolio value· pulled ahead in Year 4
10 years
BMXMF
BMXMF
● Live price
1.00%
Share price
$102.25
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.62M
Annual income
$3,874,899.32
Full BMXMF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — BMXMF vs BTI

📍 BMXMF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXMFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXMF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXMF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXMF
Annual income on $10K today (after 15% tax)
$85.29/yr
After 10yr DRIP, annual income (after tax)
$3,293,664.42/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, BMXMF beats the other by $3,291,295.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXMF + BTI for your $10,000?

BMXMF: 50%BTI: 50%
100% BTI50/50100% BMXMF
Portfolio after 10yr
$2.33M
Annual income
$1,938,842.98/yr
Blended yield
83.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

BMXMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
6.7
Piotroski
7/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXMF buys
0
BTI buys
0
No recent congressional trades found for BMXMF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXMFBTI
Forward yield1.00%5.38%
Annual dividend / share$1.03$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%11.3%
Portfolio after 10y$4.62M$37.7K
Annual income after 10y$3,874,899.32$2,786.64
Total dividends collected$4.53M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: BMXMF vs BTI ($10,000, DRIP)

YearBMXMF PortfolioBMXMF Income/yrBTI PortfolioBTI Income/yrGap
1$10,901$200.68$11,299$598.92$398.00BTI
2$12,073$408.90$12,794$703.91$721.00BTI
3$13,764$846.46$14,518$829.07$754.00BTI
4← crossover$16,532$1,803.86$16,513$978.64+$19.00BMXMF
5$21,738$4,049.60$18,827$1,157.84+$2.9KBMXMF
6$33,213$9,953.40$21,518$1,373.12+$11.7KBMXMF
7$63,964$28,425.29$24,657$1,632.46+$39.3KBMXMF
8$170,764$102,322.42$28,329$1,945.74+$142.4KBMXMF
9$693,315$510,597.75$32,637$2,325.33+$660.7KBMXMF
10$4,616,746$3,874,899.32$37,708$2,786.64+$4.58MBMXMF

BMXMF vs BTI: Complete Analysis 2026

BMXMFStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXMF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this BMXMF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXMF vs SCHDBMXMF vs JEPIBMXMF vs OBMXMF vs KOBMXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.